Morgan Stanley Upgrades DENTSPLY International (XRAY) to Overweight
- Donald Trump Sworn in as 45th U.S. President
- Wall Street ends higher as Trump becomes president
- Walgreens Boots Alliance (WBA) Said to Face Antitrust Concern for Rite Aid (RAD) Fix - Bloomberg
- Bristol-Myers Squibb (BMY) Says It Won't Pursue Accelerated U.S. Regulatory Pathway for Opdivo Plus Yervoy in Lung Cancer
- Apple (AAPL) Sues Qualcomm (QCOM) Over Patent Royalties in Antitrust Case - Bloomberg
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Morgan Stanley upgraded DENTSPLY International (NASDAQ: XRAY) from Equalweight to Overweight with a price target of $69.00.
Shares of DENTSPLY International closed at $57.57 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BofA/Merrill Lynch Upgrades CF Industries (CF) to Buy, Says "Consensus Estimates Now Beatable"
- Mitsubishi UFJ Upgrades Concho Resources (CXO) to Overweight
- Hilliard Lyons Upgrades Community Trust Bancorp (CTBI) to Neutral
Create E-mail Alert Related CategoriesHot Upgrades, Upgrades
Related EntitiesMorgan Stanley
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!